dipyridamole has been researched along with Hypertrophy, Left Ventricular in 38 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 9.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "To assess the prognostic value of dipyridamole stress echocardiography (DET) for ischemic events in a subset of patients with hypertension with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities." | 7.71 | Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities. ( Agricola, E; Ammaturo, T; Ballo, P; Barbati, R; Focardi, M; Guerrini, F; Mondillo, S; Nami, R; Picchi, A, 2001) |
| "In asymptomatic essential hypertensive patients with angiographically normal coronary arteries and without left ventricular hypertrophy, dipyridamole-induced ischemic-like ST segment depression may be a marker of coronary microvascular disease." | 5.08 | Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. ( Di Legge, V; Ghiadoni, L; Lucarini, A; Salvetti, A; Taddei, S; Virdis, A, 1996) |
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 5.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "We enrolled 129 patients with true RHTN regularly followed in our specialty hypertension clinic and evaluated then by resting and dipyridamole pharmacological stress myocardial perfusion scintigraphy." | 3.81 | Predictors of silent myocardial ischemia in resistant hypertensive patients. ( Barbaro, NR; Calhoun, DA; de Faria, AP; Fontana, V; Modolo, R; Moreno, H; Nascimento, BB; Paganelli, MO; Ramos, CD; Sabbatini, AR, 2015) |
| "Maximal wall thickness was identified as the strongest predictor of impaired dipyridamole-induced hyperemia and flow reserve in our study, whereas outflow tract obstruction was not an independent determinant." | 3.78 | PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. ( Abraham, MR; Abraham, TP; Bengel, FM; Bravo, PE; Higuchi, T; Merrill, J; Pinheiro, A; Rischpler, C; Santaularia-Tomas, M; Wahl, RL, 2012) |
| "The aims of the present study were: (a) to demonstrate whether quantitative myocardial contrast echocardiography can detect the increase in coronary flow induced by dipyridamole infusion vasodilation through the myocardial opacification due to the transit of microbubbles, both at rest and after dipyridamole induced vasodilation; (b) to explore the coronary microcirculatory function before and after dipyridamole in two different models: asymptomatic and relatively young hypertensive patients with a mild degree of left ventricular hypertrophy, and healthy controls." | 3.71 | Coronary microcirculation in essential hypertension: a quantitative myocardial contrast echocardiographic approach. ( Bertini, A; Dell'Omo, G; Di Bello, V; Giorgi, D; Mariani, M; Mengozzi, G; Nardi, C; Palagi, C; Paterni, M; Pedrinelli, R; Talini, E, 2002) |
| "To assess the prognostic value of dipyridamole stress echocardiography (DET) for ischemic events in a subset of patients with hypertension with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities." | 3.71 | Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities. ( Agricola, E; Ammaturo, T; Ballo, P; Barbati, R; Focardi, M; Guerrini, F; Mondillo, S; Nami, R; Picchi, A, 2001) |
| "We hypothesized that left ventricular (LV) cavity size measured on dipyridamole thallium scintigraphy identifies patients at risk for late nonfatal myocardial infarction and cardiovascular death." | 3.69 | Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. ( Dahlberg, S; Emlein, G; Leppo, J; Villegas, B, 1996) |
| "In 14 patients (10 men and 4 women) with arterial hypertension and 8 normotensive subjects, minimal coronary resistance and vasodilator reserve (dipyridamole: 0." | 3.68 | Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. ( Frenzel, H; Knauer, S; Motz, W; Schwartzkopff, B; Strauer, BE; Vogt, M, 1993) |
| "With carvedilol treatment, LVMI was lower (p<0." | 2.75 | Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. ( Mei, Z; Xiaozhen, H; Yu, S; Yun, Z, 2010) |
| "An all the patients with left ventricular hypertrophy (LVH) had decreased CFVR whose values with the myocardial mass index above 130 g/m2 were significantly less than those in the absence of LVH." | 1.32 | [Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension]. ( Efimova, EV; Karpov, RS; Koshel'skaia, OA; Ocheredko, NA; Panafidin, AV; Soldatenko, MV, 2004) |
| "For the secondary left ventricular hypertrophy patient group, baseline myocardial blood flow was 1." | 1.30 | Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. ( Camici, PG; Choudhury, L; Nihoyannopoulos, P; Patel, D; Rosen, SD, 1997) |
| "Left ventricular hypertrophy was detected in 34 patients, 6 of whom had coronary stenosis." | 1.30 | Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. ( Attali, JR; Blasco, A; Leutenegger, M; Lormeau, B; Metz, D; Nitenberg, A; Ouzan, J; Paries, J; Sachs, RN; Talvard, O; Taupin, JM; Valensi, P, 1997) |
| "The effect of left ventricular hypertrophy on regional vasodilating coronary capability in arterial hypertension is controversial, and no quantitative method has been applied to assess a possible correlation." | 1.30 | Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. ( Bigalli, G; Gimelli, A; Giorgetti, A; Neglia, D; Parodi, G; Parodi, O; Pedrinelli, R; Sambuceti, G; Schneider-Eicke, J, 1998) |
| "Dipyridamole treatment prevented the development of abnormal left ventricular chamber filling, preserved adrenergic responsiveness and appeared to attenuate detrimental chamber remodeling in rats with pressure overload hypertrophy." | 1.30 | Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. ( Aurigemma, GP; Chung, ES; Dobson, JG; Fenton, RA; Meyer, TE; Perlini, S, 1998) |
| "Hypertension is common in patients undergoing stress and delayed single-photon emission computed tomography (SPECT) thallium-201 myocardial perfusion imaging." | 1.29 | Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. ( Cecil, MP; Chu, TH; Eisner, RL; Merlino, JD; Patterson, RE; Pilcher, WC, 1994) |
| "Dipyridamole patients were slightly older (64 versus 57 years) and displayed more thallium redistribution (P = 0." | 1.29 | Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging. ( Bertrand, C; Cerino, M; Eybalin, MC; Lette, J; Levasseur, A; Mansur, A; McNamara, D; Nattel, S; Picard, M; Veilleux, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (47.37) | 18.2507 |
| 2000's | 16 (42.11) | 29.6817 |
| 2010's | 4 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nawathe, A | 1 |
| Ariyarajah, V | 1 |
| Apiyasawat, S | 1 |
| Barac, I | 1 |
| Spodick, DH | 1 |
| Modolo, R | 1 |
| de Faria, AP | 1 |
| Paganelli, MO | 1 |
| Sabbatini, AR | 1 |
| Barbaro, NR | 1 |
| Nascimento, BB | 1 |
| Ramos, CD | 1 |
| Fontana, V | 1 |
| Calhoun, DA | 1 |
| Moreno, H | 1 |
| Xiaozhen, H | 1 |
| Yun, Z | 1 |
| Mei, Z | 1 |
| Yu, S | 1 |
| Bravo, PE | 1 |
| Pinheiro, A | 1 |
| Higuchi, T | 1 |
| Rischpler, C | 1 |
| Merrill, J | 1 |
| Santaularia-Tomas, M | 1 |
| Abraham, MR | 1 |
| Wahl, RL | 1 |
| Abraham, TP | 1 |
| Bengel, FM | 1 |
| Di Bello, V | 2 |
| Pedrinelli, R | 3 |
| Giorgi, D | 2 |
| Bertini, A | 1 |
| Talini, E | 2 |
| Mengozzi, G | 1 |
| Palagi, C | 2 |
| Nardi, C | 2 |
| Dell'Omo, G | 2 |
| Paterni, M | 3 |
| Mariani, M | 2 |
| Kozàkovà, M | 2 |
| Palombo, C | 2 |
| Buralli, S | 1 |
| Ciardetti, M | 1 |
| Magagna, A | 1 |
| Rovai, D | 1 |
| Salvetti, A | 2 |
| Nemes, A | 2 |
| Forster, T | 2 |
| Kovács, Z | 2 |
| Thury, A | 1 |
| Ungi, I | 1 |
| Csanády, M | 2 |
| Delle Donne, MG | 1 |
| Akinboboye, OO | 1 |
| Chou, RL | 1 |
| Bergmann, SR | 1 |
| Karpov, RS | 1 |
| Koshel'skaia, OA | 1 |
| Soldatenko, MV | 1 |
| Efimova, EV | 1 |
| Ocheredko, NA | 1 |
| Panafidin, AV | 1 |
| Neu, K | 1 |
| Kjaer, A | 1 |
| Meyer, C | 1 |
| Wachtell, K | 1 |
| Olsen, MH | 1 |
| Ibsen, H | 1 |
| Opie, L | 1 |
| Holm, S | 1 |
| Hesse, B | 1 |
| Chen, ML | 1 |
| Lo, HS | 1 |
| Chao, IM | 1 |
| Su, HY | 1 |
| Shih, WJ | 1 |
| Miller, K | 1 |
| Stipp, V | 1 |
| Magour, S | 1 |
| Mazour S [corrected to Magour, S] | 1 |
| Okumoto, S | 1 |
| Morita, H | 1 |
| Hirabayashi, K | 1 |
| Mizushige, K | 1 |
| Matsuo, H | 1 |
| Arora, GD | 1 |
| Reeves, WC | 1 |
| Movahed, A | 1 |
| Cecil, MP | 1 |
| Pilcher, WC | 1 |
| Eisner, RL | 1 |
| Chu, TH | 1 |
| Merlino, JD | 1 |
| Patterson, RE | 1 |
| Zack, PM | 1 |
| Ouimette, MV | 1 |
| Chung, WM | 1 |
| Cordes, JF | 1 |
| Morris, HA | 1 |
| Veilleux, M | 1 |
| Lette, J | 1 |
| Mansur, A | 1 |
| Bertrand, C | 1 |
| Cerino, M | 1 |
| Picard, M | 1 |
| McNamara, D | 1 |
| Eybalin, MC | 1 |
| Levasseur, A | 1 |
| Nattel, S | 1 |
| Toyama, T | 1 |
| Caner, BE | 1 |
| Tamaki, N | 1 |
| Yamamoto, K | 1 |
| Nakashima, T | 1 |
| Odori, T | 1 |
| Takahashi, N | 1 |
| Mifune, J | 1 |
| Ohnaka, M | 1 |
| Tanaka, T | 1 |
| Schwartzkopff, B | 1 |
| Motz, W | 1 |
| Frenzel, H | 1 |
| Vogt, M | 1 |
| Knauer, S | 1 |
| Strauer, BE | 1 |
| Chen, D | 1 |
| Lin, J | 1 |
| Chen, J | 1 |
| Emlein, G | 1 |
| Villegas, B | 1 |
| Dahlberg, S | 1 |
| Leppo, J | 1 |
| Virdis, A | 1 |
| Ghiadoni, L | 1 |
| Lucarini, A | 1 |
| Di Legge, V | 1 |
| Taddei, S | 1 |
| Yamazaki, J | 1 |
| Igarashi, M | 1 |
| Nakata, M | 1 |
| Okamoto, K | 1 |
| Hosoi, H | 1 |
| Morishita, T | 1 |
| Nakano, H | 1 |
| Yabe, Y | 1 |
| Yoshiwara, K | 1 |
| Koyama, N | 1 |
| Nunez, E | 1 |
| Hosoya, K | 1 |
| Susic, D | 1 |
| Frohlich, ED | 1 |
| Choudhury, L | 1 |
| Rosen, SD | 1 |
| Patel, D | 1 |
| Nihoyannopoulos, P | 1 |
| Camici, PG | 1 |
| Valensi, P | 1 |
| Sachs, RN | 1 |
| Lormeau, B | 1 |
| Taupin, JM | 1 |
| Ouzan, J | 1 |
| Blasco, A | 1 |
| Nitenberg, A | 1 |
| Metz, D | 1 |
| Paries, J | 1 |
| Talvard, O | 1 |
| Leutenegger, M | 1 |
| Attali, JR | 1 |
| Gimelli, A | 1 |
| Schneider-Eicke, J | 1 |
| Neglia, D | 1 |
| Sambuceti, G | 1 |
| Giorgetti, A | 1 |
| Bigalli, G | 2 |
| Parodi, G | 1 |
| Parodi, O | 1 |
| Astarita, C | 1 |
| Nicolai, E | 1 |
| Liguori, E | 1 |
| Gambardella, S | 1 |
| Rumolo, S | 1 |
| Maresca, FS | 1 |
| Chung, ES | 1 |
| Perlini, S | 1 |
| Aurigemma, GP | 1 |
| Fenton, RA | 1 |
| Dobson, JG | 1 |
| Meyer, TE | 1 |
| Hamouda, MS | 1 |
| Kassem, HK | 1 |
| Salama, M | 1 |
| El Masry, M | 1 |
| Shaaban, N | 1 |
| Sadek, E | 1 |
| Khandheria, BK | 1 |
| Seward, JB | 1 |
| Elhendy, A | 1 |
| Galetta, F | 1 |
| Gregorini, L | 1 |
| Franzoni, F | 1 |
| Giusti, C | 1 |
| Fragasso, G | 1 |
| Mondillo, S | 1 |
| Agricola, E | 1 |
| Ammaturo, T | 1 |
| Guerrini, F | 1 |
| Barbati, R | 1 |
| Focardi, M | 1 |
| Picchi, A | 1 |
| Ballo, P | 1 |
| Nami, R | 1 |
| Beache, GM | 1 |
| Herzka, DA | 1 |
| Boxerman, JL | 1 |
| Post, WS | 1 |
| Gupta, SN | 1 |
| Faranesh, AZ | 1 |
| Solaiyappan, M | 1 |
| Bottomley, PA | 1 |
| Weiss, JL | 1 |
| Shapiro, EP | 1 |
| Hill, MN | 1 |
| Vigna, C | 1 |
| Stanislao, M | 1 |
| De Rito, V | 1 |
| Russo, A | 1 |
| Natali, R | 1 |
| Santoro, T | 1 |
| Loperfido, F | 1 |
| Arcidiacono, G | 1 |
| Privitelli, L | 1 |
| Laurenti, A | 1 |
| Vicari, E | 1 |
| Conticello, A | 1 |
| Di Mauro, C | 1 |
| Quartarone, D | 1 |
| Di Mauro, M | 1 |
| Terranova, R | 1 |
1 review available for dipyridamole and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Diagnosing coronary artery disease in patients with hypertension: a resolved dilemma?
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Disease; Diagnosis, Differential; Dipyridamole; D | 2000 |
4 trials available for dipyridamole and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
Topics: Administration, Sublingual; Adrenergic beta-Antagonists; Aged; Blood Flow Velocity; Blood Pressure; | 2010 |
[Latent impairment of left ventricular filling in hypertension without left ventricular hypertrophy and improvement by dipyridamole treatment: pulsed Doppler echocardiography study].
Topics: Adult; Aged; Diastole; Dipyridamole; Echocardiography, Doppler, Pulsed; Exercise Test; Female; Human | 1995 |
Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment.
Topics: Acetylcholine; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Circulation; Dip | 1996 |
[Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Disease; Dipyridamole; Echocard | 1998 |
33 other studies available for dipyridamole and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Correlation of echocardiographic left atrial abnormality with myocardial ischemia during myocardial perfusion assessment in the presence of known left ventricular hypertrophy.
Topics: Aged; Aged, 80 and over; Comorbidity; Coronary Artery Disease; Coronary Circulation; Diastole; Dipyr | 2013 |
Predictors of silent myocardial ischemia in resistant hypertensive patients.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Asymptomatic Diseases; Blood Pressure; Blood Pres | 2015 |
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
Topics: Adult; Aged; Algorithms; Cardiomyopathy, Hypertrophic; Coronary Circulation; Data Interpretation, St | 2012 |
Coronary microcirculation in essential hypertension: a quantitative myocardial contrast echocardiographic approach.
Topics: Adult; Case-Control Studies; Coronary Circulation; Dipyridamole; Echocardiography; Humans; Hypertens | 2002 |
Myocardial perfusion response to dipyridamole in hypertensive left ventricular hypertrophy: a human study using myocardial contrast echocardiography.
Topics: Dipyridamole; Echocardiography; Heart; Humans; Hypertrophy, Left Ventricular; Male; Myocardium; Perf | 2002 |
The effect of aortic valve replacement on coronary flow reserve in patients with a normal coronary angiogram.
Topics: Aged; Aortic Valve Stenosis; Blood Flow Velocity; Cardiac Volume; Coronary Angiography; Coronary Cir | 2002 |
Coronary microcirculation into different models of left ventricular hypertrophy-hypertensive and athlete's heart: a contrast echocardiographic study.
Topics: Adult; Blood Pressure; Case-Control Studies; Coronary Circulation; Diastole; Dipyridamole; Echocardi | 2003 |
Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy.
Topics: Adult; Age Factors; Aged; Blood Pressure; Coronary Circulation; Dipyridamole; Echocardiography; Fema | 2004 |
[Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension].
Topics: Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Dipyridamole; Echocardiogr | 2004 |
Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy.
Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Coronary Vessels; Dipy | 2005 |
Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
Topics: Adult; Aged; Coronary Circulation; Coronary Vessels; Dipyridamole; Echocardiography; Female; Heart V | 2005 |
Dipyridamole Tl-201 myocardial single photon emission computed tomography in the functional assessment of anomalous left coronary artery from the pulmonary artery.
Topics: Adolescent; Angina Pectoris; Blood Vessel Prosthesis Implantation; Cineangiography; Coronary Circula | 2007 |
Reverse redistribution on dynamic exercise and dipyridamole stress technetium-99m-MIBI myocardial SPECT.
Topics: Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Exercise Test; Heart; Humans | 1995 |
Tl-201 liver uptake for assessment of jeopardized myocardium during dipyridamole stress testing.
Topics: Aged; Blood Pressure; Dipyridamole; Electrocardiography; Female; Heart; Heart Rate; Humans; Hypertro | 1994 |
Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy.
Topics: Case-Control Studies; Dipyridamole; Exercise Test; Heart; Humans; Hypertension; Hypertrophy, Left Ve | 1994 |
The significance of transient left ventricular dilation during SPECT dipyridamole thallium-201 scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dipyridamole; Female; Humans; Hypertrophy, Left Ve | 1993 |
Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging.
Topics: Aged; Comorbidity; Coronary Disease; Dipyridamole; Exercise Test; Female; Follow-Up Studies; Humans; | 1994 |
[Transient ischemic dilatation of the left ventricle observed on dipyridamole-stressed thallium-201 scintigraphy].
Topics: Adult; Aged; Aged, 80 and over; Dipyridamole; Exercise Test; Female; Heart; Humans; Hypertrophy, Lef | 1993 |
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.
Topics: Angina Pectoris; Arterioles; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dipyridam | 1993 |
In patients with hypertensive left ventricular hypertrophy and coronary heart disease, coronary flow reserve is similarly impaired.
Topics: Adult; Aged; Aminophylline; Blood Flow Velocity; Cardiotonic Agents; Coronary Circulation; Coronary | 1995 |
Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients.
Topics: Aged; Analysis of Variance; Coronary Disease; Dipyridamole; Heart Ventricles; Humans; Hypertrophy, L | 1996 |
Estimating myocardial damage and the need for surgery in patients with valvular heart disease by Tl-201 SPECT.
Topics: Aortic Valve Insufficiency; Cardiomyopathies; Coronary Circulation; Dipyridamole; Electrocardiograph | 1996 |
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressu | 1997 |
Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Fe | 1997 |
Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiac Catheterization; Diabetes Complications; Diabete | 1997 |
Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.
Topics: Adult; Aged; Ammonia; Analysis of Variance; Chi-Square Distribution; Coronary Circulation; Coronary | 1998 |
Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat.
Topics: Adenosine; Animals; Blood Pressure; Body Weight; Dipyridamole; Heart; Hypertrophy, Left Ventricular; | 1998 |
Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal doppler echocardiography.
Topics: Angina Pectoris; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Diastole; Dipyridamole | 2000 |
Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy.
Topics: Adult; Aged; Aging; Analysis of Variance; Bicycling; Blood Flow Velocity; Blood Pressure; Coronary C | 2000 |
Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
Topics: Aged; Chest Pain; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Electrophys | 2001 |
Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging.
Topics: Adult; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Humans; Hypertension; Hypertrop | 2001 |
Dipyridamole stress echocardiography vs dipyridamole sestamibi scintigraphy for diagnosing coronary artery disease in left bundle-branch block.
Topics: Bundle-Branch Block; Coronary Disease; Dipyridamole; Echocardiography, Stress; Female; Humans; Hyper | 2001 |
[Echocardiographic evaluation of coronary flow reserve in patients with essential hypertension].
Topics: Coronary Circulation; Dipyridamole; Humans; Hypertension; Hypertrophy, Left Ventricular; Middle Aged | 2002 |